PCCA博客 保持当前PCCA新闻和事件,市场趋势,和一切雪上加霜!//www.browskids.com/Blog 在个性化医疗-蕾切尔·惠特克 //www.browskids.com/Blog/profile-in-personalized-medicine-rachelle-whitaker?PostId=108 配置文件/识别 星期一,2020年1月13日18:39:53格林尼治时间 由PCCA < p > < em > < / em > < / p > < p > < em >我们1月在个性化医疗强调蕾切尔·惠特克,CPhT,复合的复合技术实验室Huber高度,俄亥俄州。复合实验室属于PCCA成员Tim Clark,气道,并由复合药剂师Robyn乌鸦,气道。< / em > < / p > < p > < em > < / em > < / p > < p > <跨风格= "字体大小:16 px;" > < >强多长时间你复合了吗?< /强> < / span > < br / >我19岁的时候当我开始计息。我把我的第一次长期护理药店药房工作2004年。从那时起,我有机会工作在几个不同的组合设置。< / p > < p > <跨风格= "字体大小:16 px;" > < >强你了解复利是什么时候?你为什么开始复合?< /强> < / span > < br / >在过去的几年里,我学到的和未经消毒组合在长期护理工作,一个家庭输液药房和当地医院。我把我的爱令到一个新的水平,当我在2017年加入复合实验室。

I was so excited to learn how to make things like capsules, suppositories, lollipops (my favorite), troches and more. Robyn Crow, our compounding pharmacist, and the other techs taught me so much, and I am truly grateful for the knowledge they have given me. One of the things I think we do best at The Compounding Lab is hormone replacement therapy. Robyn is so great at working with doctors to develop the best regimen for each individual patient. Hormone issues affect such a large percentage of our population; I know this personally, as I suffer with polycystic ovary syndrome (PCOS). When hormones are out of whack, they can really take a toll on your physical and mental well-being, so I find it very rewarding that we are able to help our patients get that part of their lives back. Pediatric medications are another one of my favorites.

What do you find most fulfilling about compounding?
I love that we can make a medication for our patients who are children that may not be commercially available in a pediatric dosage, but could be very beneficial to their treatment. Not only does it help the child with their condition, but it also gives the parent(s) peace of mind.

What are some of your favorite PCCA formulas? What do you like about them?
My favorite PCCA formula to compound is for tetracaine lollipops (PCCA Formula #5380). We have received very good feedback from patients and their doctors. They are fun to compound, and it makes me happy that we can help these patients.

PCCA members with Clinical Services access can see Rachelle’s favorite formula for tetracaine lollipops in our formula database.

What is one of your favorite compounding success stories?
We have a young patient with rheumatoid arthritis who was practically bedridden before her doctor ordered allergy testing and found that the medications she was taking to help her arthritis were actually making her sick. Since coming to us to make her medications allergen free, she has been able to enjoy a higher quality of life.

What advice would you give to a new compounder?
I would tell them to take it slow. It takes time and patience to develop good technique. Also, take notes and do your research. There is so much to learn that it can seem overwhelming at times. I have been doing this for years and feel like I learn something new almost every day. If you stick with it, and it is something you really enjoy, it can be the best career path you will ever take!

108年
在个性化医疗——查尔斯墙 //www.browskids.com/Blog/profile-in-personalized-medicine-charles-wall?PostId=102 配置文件/识别 周五,2019年12月06 18:42:00格林尼治时间 < p > < em >这个概要文件在个性化医学强调查尔斯墙,衰变时,主人的腹地药剂师位于诺克斯维尔,田纳西州。PCCA成员自2009年以来,查尔斯对他的桑佛德大学本科毕业,药房学校教育。< / em > < br / > < / p > < p > <强>你怎么开始复合?什么使你PCCA吗?< /强> < br / >在无菌静脉药房后第一个15年的职业生涯,我完成了普渡大学核药学项目,需要我的实际时间。我在核医学培训网站,也做了一些化合物这个模型,发现有趣的一天。当我开始药房,我打算打开作为核网站第一和复合添加到我们的药房服务后,但由于市场,我翻转模型并开始加剧,永不回头。我知道PCCA很长一段时间,伸出蒂姆·亚当斯PCCA外销售一些一般性的问题,我们把它从那里。< br / > < br / > <强>你最耐心的问题是什么?你怎么解决它?< /强> < br / >我们有一位患者复发性阴道酵母对商用产品。 So we worked with her health care provider to develop a suppository that included four antibiotics and antifungals that we recommended based on her lab test results. After two rounds of therapy, the patient reported improvement and the symptoms have subsided. The patient is experiencing a reduction in pain as well as other issues. We used PCCA formulas and combined a couple in order to offer the patient ease of application, and the results have been well received.

What has been your most satisfying patient experience?
Extending the life of an elderly canine patient who was experiencing seizures. She enjoyed a year of nearly seizure-free life.

What is the biggest “aha” moment you’ve had as a member of PCCA?
The exposure to others who practice at the cutting edge of the profession. Seeing others approaching this niche area and using it to springboard onto other things and not be boxed in .

What is your favorite PCCA base, and why?
LoxaSperse® . It has so many useful applications and great results. One patient in particular had issues absorbing drugs. We tried several different capsule formulas and fillers, and we achieved adequate absorption by adding a low percentage of LoxaSperse to the formula. The resulting levels have stabilized, and the patient is now enjoying better quality of life.

What is your favorite PCCA educational event, and why?
In my first C3 compounding course at PCCA, I made some lifelong friends and was exposed to more about compounding than I ever would have expected.

When was the last time a patient thanked you?
It seems almost daily we hear from patients on hormone replacement therapy about how it has improved their lives and their spouses’ lives.

What is the one thing you would say to new compounders?
I preach it to students in each pharmacy school rotation: Use the profession as an entry to other things you enjoy — be it investing, another hobby or another profession. Pharmacy compounding allows you to grow quickly, so use that opportunity early, and you will reap many benefits later.

102年
新数据PCCA基地你不会想错过 //www.browskids.com/Blog/new-data-on-pcca-bases-you-wont-want-to-miss?PostId=94 复合创新,复合研究,一般药房复合 结婚,2019年10月30日19:37:00格林尼治时间 < div class = " PCCABlogPost " > < p > < em >由易建联Liu PharmD,博士PCCA研究药剂师< / em > < / p > < p > < br / >如果你参观了PCCA科学布斯在2019年国际研讨会,你可能感受到研究的广度和深度在PCCA——案例研究,解剖规章制度,全面分析公式,< em > < / em >新产品测试,等等。一个例子是一个有趣的案例研究关于< a href = " http://beta.pccarx.com/pdf_files/99717_CS_Spira-Wash_HandBurn.pdf " target = "平等" >的免疫抑制成人治疗烧伤创面< / >由哈尔滨制药在伯明翰,阿拉巴马州,药店PCCA的一员。除了PCCA,独立研究人员最近使用< a href = " //www.browskids.com/Products/ProductCatalog.aspx?pid = 30 - 3338“目标= "平等" > Lipoderm <一口>®< /一口> < / >在研究< a href = " https://www.ncbi.nlm.nih.gov/pubmed/31504170 " target = "平等" >改善皱纹和皮肤纹理< / >结合激光治疗。我们最近这些资源的链接添加到< a href = " //www.browskids.com/science " target = "平等" > PCCA科学网页< / >。< / p > < p >中PCCA科学页面上列出的其他物品,你不想错过一个重要的类别:技术报告。这是推出一个新的基地后尤其如此。你想知道我们的最新创新,< a href = " //www.browskids.com/Products/ProductCatalog.aspx?pid = 30 - 5056“目标= "平等" > VersaBase <一口>®< /一口>无水荷尔蒙替代疗法< / >,将雌性激素患者之前把它放在他们的皮肤吗?你想知道如果它是你的病人安全开关从另一个局部基地VersaBase无水荷尔蒙替代疗法吗? You will be able to find the answers in our technical reports. These resources provide you quick access to the most recent data generated by PCCA’s Research and Development team. The studies are always conducted to present scientific evidence on the most important properties of PCCA products. The data is publication grade, scientifically designed and reproducible, ready for you to show to your prescribers and patients. Here are some newly released technical reports:

What are the other properties of PCCA bases you think are important to know? What data about the bases are you and your physicians eager to see? Go to our webpage and look for it under the Technical Reports tab. If your answer is not there, an easy thing to do is to email PCCAScience@pccarx.com, then let us to help you address those data concerns. We’re happy to hear about the needs of your pharmacy, practitioners and patients. The whole Research and Development team is driven by this and works diligently to development new products and techniques to provide you solutions. Talk with us to make sure your needs are being heard. Maybe next year at International Seminar, the unveiled new product will be exactly what you’ve been waiting for.

Finally, here’s a sneak peek of the next PCCA Science update: Several manuscripts authored by PCCA have recently been accepted for publication in peer-reviewed journals, covering everything from clinical to regulatory topics. We will present these in the next PCCA Science post here on the blog. Stay tuned, and see you soon!


Yi Liu, PharmD, PhD, is a research pharmacist in the Research and Development department at PCCA. She joined PCCA as a clinical pharmacy researcher in the Clinical Services department in 2018 and started her current role in 2019. Yi graduated from Ohio University with a PhD in molecular and cellular biology in 2012. She also worked as a postdoctoral research fellow in the Houston Methodist Research Institute for three years prior to starting pharmacy school. Yi received her PharmD from the University of Houston College of Pharmacy in 2019.

94年